[1] RONCO C, CICOIRA M, MCCULLOUGH P A. Cardiorenal syndrome type 1:pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure[J]. J Am Coll Cardiol, 2012,60(12):1031-1042. [2] DAMMAN K, TESTANI J M. The kidney in heart failure:an update[J]. Eur Heart J, 2015, 36(23):1437-1444. [3] DAMMAN K, TANG W H, TESTANI J M, et al. Terminology and definition of changes renal function in heart failure[J]. Eur Heart J, 2014, 35(48):3413-3416. [4] BAGSHAW S M, CRUZ D N, ASPROMONTE N, et al. Epidemiology of cardio-renal syndromes:workgroup statements from the 7th ADQI Consensus Conference[J]. Nephrol Dial Transplant,2010,25(5):1406-1416. [5] 叶婷, 张宇, 张梦, 等. 中医药治疗慢性心力衰竭药理机制研究进展[J]. 中西医结合心脑血管病杂志, 2016, 14(8):841-843. [6] 苏志远, 叶小汉, 吴锦波. 心康方治疗慢性心力衰竭临床观察[J]. 新中医, 2016, 48(3):12-14. [7] 孙慧萍, 曹军平, 徐丽, 等. 丹皮酚对动脉粥样硬化大鼠炎症因子的影响[J]. 中华中医药学刊, 2016, 34(1):14-16. [8] LU L, QIN Y T, CHEN C,et al. Beneficial effects exerted by paeonol in the management of atherosclerosis[J].Oxid Med Cell Longev, 2018, 2018:1098617. [9] 张竞之, 陈小忆, 金伟孝, 等. 丹皮酚对高血压病血瘀证患者血清损伤的HUVEC-C形态学、活性的影响[J]. 辽宁中医药大学学报, 2012, 14(6):29-31. [10] 陆建洪, 翟昌林, 陈捷. 丹皮酚对大鼠缺血再灌注损伤心肌细胞凋亡及其Bcl-2和Bax表达的影响[J]. 中国中医药科技, 2013, 20(2):151-152. [11] SUEMATSU Y, JING W H, NUNES A,et al. LCZ696(sacubitril/valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis, and vasculopathy in a rat model of chronic kidney disease[J]. J Card Fail, 2018,24(4):266-275. [12] HAO G P, ZHAI J, JIANG H M, et al. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling[J].Biomed Pharmacother, 2019, 122:109677. [13] LIU X Y, CHEN J Y, LI W, et al. Inhibition of casein kinase Ⅱ by CX-4945, but not yes-associated protein (YAP) by verteporfin, enhances the antitumor efficacy of temozolomide in glioblastoma[J].Transl Oncol, 2020, 13(1):70-78. [14] BELOUSOV V V, FRADKOV A F, LUKYANOV K A, et al. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide[J]. Nat Methods, 2006, 3(4):281-286. [15] BERTERO E, MAACK C. Metabolic remodelling in heart failure[J]. Nat Rev Cardiol, 2018,15(8):457-470. [16] VON LUEDER T G, WANG B H, KOMPA A R, et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy[J]. Circ Heart Fail, 2015, 8(1):71-78. [17] BOEHM O, ZUR B, KOCH A, et al. Clinical chemistry reference database for Wistar rats and C57/BL6 mice[J]. Biol Chem, 2007,388(5):547-554. [18] BRAISSANT O, MCLIN V A, CUDALBU C. Ammonia toxicity to the brain[J].J Inherited Metab Dis, 2013,36:595-612. [19] ZHANG X X,ZHAI Y H,YUAN J H, et al. New insights into Paeoniaceae used as medicinal plants in China[J].Sci Rep, 2019, 9(1):18469. [20] CHEN G, JIA P, YIN Z Y, et al. Paeonol ameliorates monosodium urate-induced arthritis in rats through inhibiting nuclear factor-κB-mediated proinflammatory cytokine production[J].Phytother Res, 2019, 33:2971-2978. [21] BRAUNWALD E. Heart failure[J]. JACC, 2013,1:1-20. [22] STEINHORN B, SORRENTINO A, BADOLE S, et al. Chemogenetic generation of hydrogen peroxide in the heart induces severe cardiac dysfunction[J]. Nat Commun, 2018, 9(1):4044. |